Halda Therapeutics

Acquired

Taking Hold. Conquering Cancer.

New Haven, United States · Founded 2019 · $202.0M raised

Employees
1–10
Founded
2019
Business Model
B2B
Total Funding
$202.0M
Last Round
$126.0M Series BAug 2024
Rounds
2
Acquired by
Johnson & JohnsonNov 2025 · $3.0B

About

Halda Therapeutics is a clinical-stage biotechnology company founded in 2019 by Yale professor Craig Crews to develop RIPTAC (Regulated Induced Proximity TArgeting Chimeras) therapeutics, a novel precision-medicine class designed to selectively target and destroy cancer cells while sparing healthy tissue. Headquartered in New Haven, Connecticut, the company was acquired by Johnson & Johnson for approximately $3 billion in 2025.

Summary

Halda Therapeutics is a Biotech company based in New Haven, United States, founded in 2019. It has raised $202.0M in total across 2 rounds, most recently a $126.0M Series B round in Aug 2024. Investors include Johnson & Johnson Innovation, RA Capital Management and Canaan Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

AcquisitionNov 2025

Sign up to see all 3 rounds

Series A through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Halda Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/halda-therapeutics"><img src="https://indexed.vc/api/badge/company/halda-therapeutics" alt="Halda Therapeutics on Indexed.vc" width="260" height="76" /></a>